DECCO, Inc. Provides Process Piping Services for  Pfizer’s Award-Winning Building E – Andover Clinical Manufacturing Facility

Project Recognized with International Society of Pharmaceutical Engineering Facility of the Year Award for Facility Integration

Brookline, NH, — The International Society of Pharmaceutical Engineering (ISPE) has announced that Pfizer’s Building E – Andover Clinical Manufacturing Facility is the recipient of the 2020 Facility of the Year Awards (FOYA) in the Facility Integration category.  The ACMF proves that a sustainable, flexible, configurable, and wireless clinical manufacturing facility can achieve complete integration into a dynamic, high-performance process development flow today and preserve that integration no matter how biologic drug development may evolve in years to come.

DECCO, Inc. served as process piping contractor for the new 175,000 sf facility that focuses on integration and flexibility to speed patient therapies.  The new facility enables Pfizer’s BioTherapeutics Pharmaceutical Sciences group to move its clinical manufacturing capabilities from Chesterfield, Missouri to Andover, Massachusetts.   Learn more about this project.

FOYA is the premier global awards program recognizing innovation and creativity in manufacturing facilities serving the regulated healthcare industry. The award-winning projects selected by the FOYA program set the standard for pharmaceutical facilities of the future by demonstrating excellence in facility design, construction, and operations.

“For this project, an extremely aggressive schedule required DECCO to execute tactics not previously utilized on such a facility, the pre-fabrication plan that allowed half of the piping systems to be fabricated prior to work commencing on-site,” notes Kyle Reagan, CEO, DECCO, Inc.   “When the super skids could not be installed as constructed, DECCO’s team developed a work-around plan that allowed on-site construction to continue as the skids were modified and repaired ensuring the project schedule would not be comprised.”

“Technology and innovation in the pharmaceutical industry are more critical now than ever before as healthcare worldwide is straining from the COVID-19 pandemic,” said Tom Hartman, President and CEO, ISPE. “Even in these trying times, it is important to spotlight the dedication of companies like the 2020 FOYA Category Winners who are at the forefront of not only setting the standard for pharmaceutical facilities of the future but also creating new opportunities to enhance patient health and safety worldwide.”

About ISPE

The International Society for Pharmaceutical Engineering (ISPE) is the world’s largest not-for-profit association serving its members through leading scientific, technical, and regulatory advancement across the entire pharmaceutical lifecycle. The 18,500 members of ISPE are building solutions in the development and manufacture of safe, effective pharmaceutical and biologic medicines, and medical delivery devices in more than 90 countries around the world. Founded in 1980, ISPE has its worldwide headquarters and training center in North Bethesda, Maryland USA, and its operations center in Tampa, Florida USA. Visit for more information.